Skip to content

Clinical trials

Observational Retinal Degeneration trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinal Degeneration Phase: Observational Country / region: United States Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20111
20121
20132
20151
20162
20172
20192
20201
20212
20235

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting6
Recruiting4
Terminated2
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Eye Institute (NEI)4
Nanoscope Therapeutics Inc.3
4D Molecular Therapeutics1
Adverum Biotechnologies, Inc.1
Beacon Therapeutics1
Complement Therapeutics1
Editas Medicine, Inc.1
Food and Drug Administration (FDA)1
Foundation Fighting Blindness1
Gyroscope Therapeutics Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinal Degeneration21
Retinitis Pigmentosa8
Macular Degeneration7
Eye Diseases6
Retinal Diseases6
Eye Diseases, Hereditary4
Retinal Dystrophies4
Choroideremia3
Geographic Atrophy3
Stargardt Disease3

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.